BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37735716)

  • 1. A 5-year single-center study about onychomycosis with a focus on Aspergillus spp. in Albania.
    Fida M; Prendushi XF; Gjylameti N; Dedej S; Zenelaj V; Toçi E; Vasili E
    Int J Dermatol; 2023 Nov; 62(11):1365-1370. PubMed ID: 37735716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspergillus species as emerging causative agents of onychomycosis.
    Nouripour-Sisakht S; Mirhendi H; Shidfar MR; Ahmadi B; Rezaei-Matehkolaei A; Geramishoar M; Zarei F; Jalalizand N
    J Mycol Med; 2015 Jun; 25(2):101-7. PubMed ID: 25656408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-dermatophytic molds as agents of onychomycosis in Izmir, Turkey - a prospective study.
    Hilmioğlu-Polat S; Metin DY; Inci R; Dereli T; Kilinç I; Tümbay E
    Mycopathologia; 2005 Sep; 160(2):125-8. PubMed ID: 16170607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nondermatophyte molds: Emerging as leading cause of onychomycosis in south-east Rajasthan.
    Raghavendra KR; Yadav D; Kumar A; Sharma M; Bhuria J; Chand AE
    Indian Dermatol Online J; 2015; 6(2):92-7. PubMed ID: 25821729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review of Onychomycosis Due to Aspergillus Species.
    Bongomin F; Batac CR; Richardson MD; Denning DW
    Mycopathologia; 2018 Jun; 183(3):485-493. PubMed ID: 29147866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and histological aspects of toenail onychomycosis caused by Aspergillus spp.: 34 cases treated with weekly intermittent terbinafine.
    Gianni C; Romano C
    Dermatology; 2004; 209(2):104-10. PubMed ID: 15316163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycological aspects of onychomycosis in Khuzestan Province, Iran: A shift from dermatophytes towards yeasts.
    Fatahinia M; Jafarpour S; Rafiei A; Taghipour S; Makimura K; Rezaei-Matehkolaei A
    Curr Med Mycol; 2017 Dec; 3(4):26-31. PubMed ID: 29707676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspergillus terreus complex: an emergent opportunistic agent of Onychomycosis.
    Fernández MS; Rojas FD; Cattana ME; Sosa Mde L; Mangiaterra ML; Giusiano GE
    Mycoses; 2013 Jul; 56(4):477-81. PubMed ID: 23448599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical and mycological study of onychomycosis in HIV infection.
    Surjushe A; Kamath R; Oberai C; Saple D; Thakre M; Dharmshale S; Gohil A
    Indian J Dermatol Venereol Leprol; 2007; 73(6):397-401. PubMed ID: 18032858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growing Incidence of Non-Dermatophyte Onychomycosis in Tehran, Iran.
    Motamedi M; Ghasemi Z; Shidfar MR; Hosseinpour L; Khodadadi H; Zomorodian K; Mirhendi H
    Jundishapur J Microbiol; 2016 Aug; 9(8):e40543. PubMed ID: 27800138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular detection of dermatophytes and nondermatophytes in onychomycosis by nested polymerase chain reaction based on 28S ribosomal RNA gene sequences.
    Ebihara M; Makimura K; Sato K; Abe S; Tsuboi R
    Br J Dermatol; 2009 Nov; 161(5):1038-44. PubMed ID: 19566663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Dermatophyte Mold Dominated Onychomycosis in Patients Attending a Rank Higher Specialized Dermatology Clinic in Addis Ababa, Ethiopia.
    Bitew A; Osman F; Yassin S
    Clin Cosmet Investig Dermatol; 2022; 15():507-518. PubMed ID: 35356385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of Onychomycosis in an Academic Nail Unit in South Greece during a Three-Year Period.
    Gregoriou S; Mpali N; Vrioni G; Hatzidimitriou E; Chryssou SE; Rigopoulos D
    Skin Appendage Disord; 2020 Mar; 6(2):102-107. PubMed ID: 32258053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Dermatophyte and Non-Dermatophyte Agents in Onychomycosis by PCR and DNA Sequencing-A Retrospective Comparison of Diagnostic Tools.
    Pospischil I; Reinhardt C; Bontems O; Salamin K; Fratti M; Blanchard G; Chang YT; Wagner H; Hermann P; Monod M; Hoetzenecker W; Guenova E
    J Fungi (Basel); 2022 Sep; 8(10):. PubMed ID: 36294584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study on clinico-mycological profile, aetiological agents and diagnosis of onychomycosis at a government medical college hospital in kashmir.
    Lone R; Bashir D; Ahmad S; Syed A; Khurshid S
    J Clin Diagn Res; 2013 Sep; 7(9):1983-5. PubMed ID: 24179915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onychomycosis in Malaysia.
    Ng KP; Saw TL; Madasamy M; Soo Hoo T
    Mycopathologia; 1999; 147(1):29-32. PubMed ID: 10872513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onychomycosis in Iran: epidemiology, causative agents and clinical features.
    Aghamirian MR; Ghiasian SA
    Nihon Ishinkin Gakkai Zasshi; 2010; 51(1):23-9. PubMed ID: 20185868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current mycological profile of onychomycosis in Kashmir valley: A hospital-based study.
    Asifa N; Farhath K
    J Lab Physicians; 2017; 9(3):190-194. PubMed ID: 28706389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Incidence of Onychomycosis Infection among Patients Referred to Hospitals in Kermanshah Province, Western Iran.
    Mikaeili A; Karimi I
    Iran J Public Health; 2013; 42(3):320-5. PubMed ID: 23641410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pattern of onychomycosis--a RIMS study.
    Pukhrambam PD; Devi KhR; Singh NB
    J Commun Dis; 2011 Jun; 43(2):105-12. PubMed ID: 23785867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.